77 related articles for article (PubMed ID: 9371039)
1. Usefulness of paraclinical follow-up in stage I melanoma.
Bastien M; Tessier MH; Legoux B; Litoux P; Bureau B; Dréno B
Arch Dermatol; 1997 Nov; 133(11):1462-3. PubMed ID: 9371039
[No Abstract] [Full Text] [Related]
2. [Modalities of follow-up after excision of stage I melanoma: practice survey in hospitals].
Couilliet D; Poisson-Salomon AS; Cosquer M; Guillaume JC
Ann Dermatol Venereol; 1995; 122(5):263-6. PubMed ID: 8572463
[No Abstract] [Full Text] [Related]
3. Method of detection of initial recurrence of stage II/III cutaneous melanoma: analysis of the utility of follow-up staging.
Meyers MO; Yeh JJ; Frank J; Long P; Deal AM; Amos KD; Ollila DW
Ann Surg Oncol; 2009 Apr; 16(4):941-7. PubMed ID: 19101766
[TBL] [Abstract][Full Text] [Related]
4. Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma.
Poo-Hwu WJ; Ariyan S; Lamb L; Papac R; Zelterman D; Hu GL; Brown J; Fischer D; Bolognia J; Buzaid AC
Cancer; 1999 Dec; 86(11):2252-8. PubMed ID: 10590365
[TBL] [Abstract][Full Text] [Related]
5. Follow-up of patients with a thin melanoma.
Johnson RC; Fenn NJ; Horgan K; Mansel RE
Br J Surg; 1999 May; 86(5):619-21. PubMed ID: 10361181
[TBL] [Abstract][Full Text] [Related]
6. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
[TBL] [Abstract][Full Text] [Related]
7. Patterns of first-recurrence and post-recurrence survival in patients with primary cutaneous melanoma after sentinel lymph node biopsy.
Dalal KM; Patel A; Brady MS; Jaques DP; Coit DG
Ann Surg Oncol; 2007 Jun; 14(6):1934-42. PubMed ID: 17406951
[TBL] [Abstract][Full Text] [Related]
8. [Manifestations of the "pretherapeutic phase" of malignant melanoma of the skin in Switzerland 1996-1998].
Schnorf M; Helfenstein U; Blum A; Ellwanger U; Garbe C; Burg G; Dummer R
Praxis (Bern 1994); 2001 Dec; 90(50):2193-8. PubMed ID: 11793837
[TBL] [Abstract][Full Text] [Related]
9. Is sentinel node status predictive of overall survival in patients with melanoma?
Carlson GW
Nat Clin Pract Oncol; 2005 Oct; 2(10):494-5. PubMed ID: 16205765
[No Abstract] [Full Text] [Related]
10. Outcomes of patients with brain metastases from melanoma and renal cell carcinoma after primary stereotactic radiosurgery.
Jensen RL; Shrieve AF; Samlowski W; Shrieve DC
Clin Neurosurg; 2008; 55():150-9. PubMed ID: 19248682
[No Abstract] [Full Text] [Related]
11. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
[TBL] [Abstract][Full Text] [Related]
12. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ
Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183
[TBL] [Abstract][Full Text] [Related]
13. [Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up].
Francken AB; Thompson JF; Bastiaannet E; Hoekstra HJ
Ned Tijdschr Geneeskd; 2008 Mar; 152(10):557-62. PubMed ID: 18402322
[TBL] [Abstract][Full Text] [Related]
14. [Clinical aspects of cutaneous melanoma: atlas].
Avril MF
Rev Prat; 2004 Jun; 54(11):1187-92. PubMed ID: 15496025
[No Abstract] [Full Text] [Related]
15. Patterns of recurrence in patients with melanoma after radical lymph node dissection.
Badruddoja M
Arch Surg; 2006 Nov; 141(11):1145; author reply 1145-6. PubMed ID: 17116810
[No Abstract] [Full Text] [Related]
16. Gamma knife radiosurgery for malignant melanoma brain metastases.
Mathieu D; Kondziolka D; Cooper PB; Flickinger JC; Niranjan A; Agarwala S; Kirkwood J; Lunsford LD
Clin Neurosurg; 2007; 54():241-7. PubMed ID: 18504926
[No Abstract] [Full Text] [Related]
17. The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up.
Francken AB; Shaw HM; Thompson JF; Soong SJ; Accortt NA; Azzola MF; Scolyer RA; Milton GW; McCarthy WH; Colman MH; McGovern VJ
Ann Surg Oncol; 2004 Apr; 11(4):426-33. PubMed ID: 15070604
[TBL] [Abstract][Full Text] [Related]
18. Dermacase. Melanoma.
Turchin I; Adams S
Can Fam Physician; 2007 Apr; 53(4):633, 647-8. PubMed ID: 17882758
[No Abstract] [Full Text] [Related]
19. S100 serum level: a tumour marker for metastatic melanoma.
Bottoni U; Izzo P; Richetta A; Mannooranparampil TJ; Devirgiliis V; Del Giudice M; Reale MG; Frati L; Calvieri S
Melanoma Res; 2003 Aug; 13(4):427-9. PubMed ID: 12883371
[No Abstract] [Full Text] [Related]
20. Correlation of positive RT-PCR for tyrosinase in peripheral blood of malignant melanoma patients with clinical stage, survival and other risk factors.
Proebstle TM; Jiang W; Högel J; Keilholz U; Weber L; Voit C
Br J Cancer; 2000 Jan; 82(1):118-23. PubMed ID: 10638977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
